Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study

Jakob Medbo1,2, Henrik Imberg3, Christine Hansen4

  • 1Department of Pediatrics, Institute of Clinical Science at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

PubMed

Insights

Telehealth and home spirometry in cystic fibrosis (CF) care showed no negative impact on disease progression. This approach offers flexibility and personalization, with high patient and caregiver satisfaction.

Area of Science:

  • Pediatric Pulmonology
  • Digital Health
  • Chronic Disease Management

Background:

  • Feasibility of telehealth and home spirometry for pediatric cystic fibrosis (CF) patients is established.
  • Impact of these technologies on CF disease progression requires assessment.

Purpose of the Study:

  • Evaluate the effects of integrating telehealth and home spirometry into CF care.
  • Assess the impact on disease progression and overall patient care.

Main Methods:

  • Children with CF (5-17 years) used home spirometers, replacing some in-person visits with telemedicine.
  • Compared disease progression trajectories (FEV1%, lung clearance index, BMI) using linear mixed-effects models.
  • Collected data on airway pathogens, sputum cultures, antibiotic use, and patient/caregiver stress levels.

Main Results:

  • No significant differences in FEV1%, lung clearance index, or BMI progression rates were observed between telehealth/home spirometry and pre-pandemic in-person care.
  • No significant changes in airway pathogen incidence, sputum cultures, or antibiotic use.
  • The intervention did not increase patient or caregiver stress; high satisfaction reported.

Conclusions:

  • Combining telehealth and home spirometry with in-person visits provides comparable effectiveness to traditional care.
  • This integrated approach enhances flexibility and personalization in managing pediatric cystic fibrosis.
  • High patient and caregiver preference for continuing telehealth and home spirometry services.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
154
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
316
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
205
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
424